Non-selective beta-adrenergic receptor blocker

This page covers all Non-selective beta-adrenergic receptor blocker drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-adrenergic receptors.

Targets

Beta-adrenergic receptors

Phase 3 pipeline (1)

• timolol 0.5% BID · Inotek Pharmaceuticals Corporation · Ophthalmology
  Timolol is a non-selective beta-adrenergic receptor blocker that reduces intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow.

Patent intelligence

• non selective beta adrenergic receptor blocker patent landscape — aggregated cliff calendar, attackable patents, originator estates